Details of the Drug-Related molecule(s) Activity Atlas
General Information of Drug (ID: DM02FGH)
| Drug Name | ||||||
|---|---|---|---|---|---|---|
| Synonyms |
UK 356618; 230961-08-7; CHEMBL117225; UK-356,618; SCHEMBL6437730; GTPL6528; CHEBI:94305; DTXSID50438778; MolPort-023-277-089; ZINC3924338; BDBM50097263; AKOS024458021; FT-0675728; PF 03890101; PF-03890101; UK-356618, > J-014983; BRD-K57011718-001-01-5; (R)-N*1*-[(S)-2,2-Dimethyl-1-((R)-1-phenyl-ethylcarbamoyl)-propyl]-N*4*-hydroxy-2-[3-(2-methyl-biphenyl-4-yl)-propyl]-succinamide
|
|||||
| Cross-matching ID | ||||||
Molecule-level Activity Landscape of This Drug
|
|
||||||||||||||||||
|
||||||||||||||||||
Experimental Drug Sensitivity Data Across Cancer Cell Lines
|
|
||||||||||||||||
|
||||||||||||||||
